Opko Health, Inc.
OPK
$1.28
-$0.02-1.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 149.95M | 183.64M | 173.63M | 182.19M | 173.69M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 149.95M | 183.64M | 173.63M | 182.19M | 173.69M |
| Cost of Revenue | 138.17M | 129.40M | 162.27M | 154.62M | 153.55M |
| Gross Profit | 11.78M | 54.23M | 11.36M | 27.57M | 20.13M |
| SG&A Expenses | 59.09M | 67.03M | 98.20M | 68.82M | 70.17M |
| Depreciation & Amortization | 19.86M | 20.34M | 20.43M | 20.42M | 21.44M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 217.12M | 216.78M | 280.91M | 243.86M | 245.16M |
| Operating Income | -67.17M | -33.14M | -107.28M | -61.67M | -71.47M |
| Income Before Tax | -73.38M | 34.97M | 48.42M | -10.59M | -83.19M |
| Income Tax Expenses | -5.77M | 20.95M | 23.53M | -280.00K | -1.35M |
| Earnings from Continuing Operations | -67.61M | 14.03M | 24.89M | -10.31M | -81.84M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -67.61M | 14.03M | 24.89M | -10.31M | -81.84M |
| EBIT | -67.17M | -33.14M | -107.28M | -61.67M | -71.47M |
| EBITDA | -43.68M | -9.10M | -83.11M | -37.52M | -45.65M |
| EPS Basic | -0.10 | 0.02 | 0.04 | -0.01 | -0.12 |
| Normalized Basic EPS | -0.07 | 0.13 | -0.11 | 0.01 | -0.07 |
| EPS Diluted | -0.10 | 0.02 | 0.03 | -0.01 | -0.12 |
| Normalized Diluted EPS | -0.07 | 0.09 | -0.07 | 0.01 | -0.07 |
| Average Basic Shares Outstanding | 671.58M | 676.79M | 694.62M | 697.21M | 706.88M |
| Average Diluted Shares Outstanding | 671.58M | 951.84M | 998.36M | 697.21M | 706.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |